Shuguang Huang, PhD (Stat4ward)
Conference Chair
Dr. Shuguang Huang has 20 years of experience working in pharmaceutical and diagnostic companies. He had assumed technical and management positions at Eli Lilly, Wyeth, and Pfizer. His most position was Associate VP, department head of Biostatistics at Helomics, a cancer diagnostic company. In 2014, he co-founded and assumed the Chief Scientific Officer position for the statistics consulting company Stat4ward.
His expertise includes (i) In-depth real-life expertise in assay development and validation. (ii) data mining and exploratory analysis using high-throughput assay technologies. (iii) Broad experience with various assay technologies and their applications in drug development and biomarker assay development. (iv) Statistical process control. (v) IVD/LTD regulatory submission – PMA, 510(k), CLIA.
Dr. Huang is a committee member of AAPS Flow Cytometry Action Programming Committee, and he is the committee members for a few CLSI guideline development teams. He has conducted a few workshops across US teaching Assay validation based on CLSI guidelines. He has 30 peer-reviewed publications.
